Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H15NO3 |
Molecular Weight | 149.1882 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN(CCO)CCO
InChI
InChIKey=GSEJCLTVZPLZKY-UHFFFAOYSA-N
InChI=1S/C6H15NO3/c8-4-1-7(2-5-9)3-6-10/h8-10H,1-6H2
Molecular Formula | C6H15NO3 |
Molecular Weight | 149.1882 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TROLAMINE&audience=professional;Curator's Comment: Description was created using several sources including:
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/11340s16lbl.pdf; https://www.ons.org/intervention/trolamine-biafine®; https://www.ncbi.nlm.nih.gov/pubmed/?term=15084618; https://clinicaltrials.gov/ct2/show/NCT02729324; http://www.ncbi.nlm.nih.gov/pubmed/18441842
Sources: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TROLAMINE&audience=professional;
Curator's Comment: Description was created using several sources including:
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/11340s16lbl.pdf; https://www.ons.org/intervention/trolamine-biafine®; https://www.ncbi.nlm.nih.gov/pubmed/?term=15084618; https://clinicaltrials.gov/ct2/show/NCT02729324; http://www.ncbi.nlm.nih.gov/pubmed/18441842
Trolamine, an organic compound, is the salt formed between triethanolamine and salicylic acid. It is widely used as a topical analgesic. 10% trolamine salicylate medical products sold over-the-counter such as are creams for temporarily relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, lumbago, neuralgia, strains, bruises, and sprains. The FDA approved in 1958 otic solution drops containing triethanolamine polypeptide used in the ear to break down and loosen earwax was discontinued. Trolamine can enhance skin healing by recruiting macrophages and modifying the concentrations of various immunomodulators. Trolamine (Biafine; Genmedix Ltd, France) is commonly prescribed at the beginning of radiotherapy for preventing acute radiation-induced skin toxicity in China. Biafine has been studied in radiodermatitis and Phase 2 clinical trial has been initiated in 2016 by Sun Yat-sen University to establish the efficacy of trolamine (Biafine) for the management of radiation dermatitis in patients with nasopharyngeal carcinoma receiving IMRT.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | Volu-Firm Approved UseUnknown |
|||
Palliative | CERUMENEX Approved UseFor removal of impacted cerumen prior to ear examination, otologic therapy and/or audiometry. CERUMENEX Eardrops should be used only with caution in external otitis. Launch Date1958 |
Doses
Dose | Population | Adverse events |
---|---|---|
5.38 mg 2 times / day multiple, topical Studied dose Dose: 5.38 mg, 2 times / day Route: topical Route: multiple Dose: 5.38 mg, 2 times / day Sources: |
unhealthy, 21.6–84.9 n = 15 Health Status: unhealthy Condition: Wound Age Group: 21.6–84.9 Sex: M+F Population Size: 15 Sources: |
Disc. AE: Application site erythema... AEs leading to discontinuation/dose reduction: Application site erythema (6.7%) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Application site erythema | 6.7% Disc. AE |
5.38 mg 2 times / day multiple, topical Studied dose Dose: 5.38 mg, 2 times / day Route: topical Route: multiple Dose: 5.38 mg, 2 times / day Sources: |
unhealthy, 21.6–84.9 n = 15 Health Status: unhealthy Condition: Wound Age Group: 21.6–84.9 Sex: M+F Population Size: 15 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Preliminary assessment of selected methacrylic acid--acrylic acid copolymers as factors buffering triethanolamine interacting with artificial skin sebum. | 2001 |
|
[Enantiomeric separation of drugs with capillary electrophoresis with cyclodextrins]. | 2001 |
|
Fluorescent derivatization of nitrite ions with 2,3-diaminonaphthalene utilizing a pH gradient in a Y-shaped microchannel. | 2001 Apr |
|
In vitro percutaneous absorption of tenoxicam from pressure-sensitive adhesive matrices across the hairless mouse skin. | 2001 Dec |
|
Vanadium, molybdenum, and sodium triethanolamine complexes derived from an assembly system containing tetrathiometalate and triethanolamine. | 2001 Jul 16 |
|
Luminol chemiluminescence in unbuffered solutions with a cobalt(II)-ethanolamine complex immobilized on resin as catalyst and its application to analysis. | 2001 Nov 1 |
|
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. | 2002 Apr 2 |
|
Analysis of illicit amphetamine seizures by capillary zone electrophoresis. | 2002 Dec 6 |
|
Enantiomeric separation of TAPP, H-Tyr-(D)Ala-Phe-Phe-NH(2), by capillary electrophoresis using 18-crown-6-tetracarboxylic acid as a chiral selector. | 2003 Aug 15 |
|
Dynamic localization of SPE-9 in sperm: a protein required for sperm-oocyte interactions in Caenorhabditis elegans. | 2003 Dec 3 |
|
Correlation between pK(a) and reactivity of quinuclidine-based catalysts in the Baylis-Hillman reaction: discovery of quinuclidine as optimum catalyst leading to substantial enhancement of scope. | 2003 Feb 7 |
|
Capillary electrophoresis determinations of trace concentrations of inorganic ions in large excess of chloride: soft modelling using artificial neural networks for optimisation of electrolyte composition. | 2003 Jun |
|
Preliminary assessment of alginic acid as a factor buffering triethanolamine interacting with artificial skin sebum. | 2003 Mar |
|
Synthesis of uniform anatase TiO2 nanoparticles by gel-sol method. 4. Shape control. | 2003 Mar 1 |
|
Substantial increase of the ordering temperature for [MnII/MoIII(CN)7]-based magnets as a function of the 3d ion site geometry: example of two supramolecular materials with Tc = 75 and 106 K. | 2003 Mar 10 |
|
Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. | 2003 May-Jun |
|
Reactivity with Tris(hydroxymethyl)aminomethane confounds immunodetection of acrolein-adducted proteins. | 2003 Oct |
|
Carbopols as factors buffering triethanolamine interacting with artificial skin sebum. | 2004 |
|
Effect of some anionic polymers on pH of triethanolamine aqueous solutions. | 2004 |
|
Evaluation of method of preparation of passive diffusion tubes for measurement of ambient nitrogen dioxide. | 2004 Jan |
|
Mechanical and water barrier properties of glutenin films influenced by storage time. | 2004 Jan 14 |
|
Quantitation of biomarkers of exposure to nitrogen mustards in urine from rats dosed with nitrogen mustards and from an unexposed human population. | 2004 Jul-Aug |
|
Evaluation of the potential of triethanolamine to alter hepatic choline levels in female B6C3F1 mice. | 2004 Jun |
|
Alternative approach to enhancing cation selectivity in ion chromatography. | 2004 Jun 11 |
|
Titanatranes derailed: static and dynamic triethanolamine slippage induced by polyphenoxide chelation. | 2004 Nov 1 |
|
Efficient photocurrent generation by self-assembled monolayers composed of 3 10-helical peptides carrying linearly spaced naphthyl groups at the side chains. | 2004 Oct 13 |
|
Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG). | 2004 Sep |
|
Co phytoavailability for tomato in amended calcareous soils. | 2005 Apr |
|
Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. | 2005 Feb 14 |
|
Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes. | 2005 Jan 21 |
|
Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach. | 2005 Jan 25 |
|
New structural motifs in manganese single-molecule magnetism from the use of triethanolamine ligands. | 2005 Jan 28 |
|
Ion chromatographic analysis of amines, alkanolamines, and associated anions in concrete. | 2005 Mar |
|
A factor analysis for complex systems containing nimesulide. | 2005 Mar |
|
Photoreduction behavior of cytochrome c by zinc porphyrin in lipid media. | 2005 May 13 |
|
Effect of cationic micellar aggregates on the kinetics of oxidation of aminoalcohols by N-bromosuccinimide in alkaline medium. | 2005 May 15 |
Sample Use Guides
Fill ear canal with ear drops of 10% triethanolamine Polypeptide Oleate-Condensate with the patient’s head tilted at a 45° angle. Insert cotton plug and allow to remain 15-30 minutes. Then gently flush with lukewarm water, using a soft rubber syringe (avoid excessive pressure). Exposure of skin outside the ear to the drug should be avoided. The procedure may be repeated if the first application fails to clear the impaction.
Route of Administration:
Otic (auricular)
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/?term=15850295
Penetration of triethanolamine into artificial skin sebum and its uplift were measured using 0.1 M aqueous triethanolamine solution.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:03:16 GMT 2023
by
admin
on
Fri Dec 15 16:03:16 GMT 2023
|
Record UNII |
9O3K93S3TK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
D03AX12
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
||
|
EPA PESTICIDE CODE |
4208
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2768
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL446061
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
m11100
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | Merck Index | ||
|
TRIETHANOLAMINE
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
203-049-8
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
561
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
28621
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
SUB12376MIG
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
9O3K93S3TK
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
DTXSID9021392
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
1696958
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
38623
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB13747
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
100000079034
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
36718
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
9O3K93S3TK
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
C009546
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
7618
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
C80948
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
102-71-6
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
893
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|